Haplotype analysis and age estimation of the 113insR CDKN2A founder mutation in Swedish melanoma families
The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Germline mutations in the CDKN2A tumor suppressor gene located on 9p21 have been linked to development of melanomas in some families. A germline 3‐bp insertion in exon 2 of CDKN2A, leading to an extra arginine at codon 113 (113insR), has been identified in 17 Swedish melanoma families. Analysis of 10 microsatellite markers, spanning approximately 1 Mbp in the 9p21 region, showed that all families share a common allele for at least one of the markers closest to the CDKN2A gene, suggesting that the 113insR mutation is an ancestral founder mutation. Differences in the segregating haplotypes, due to meiotic recombinations and/or mutations in the short‐tandem‐repeat markers, were analyzed further to estimate the age of the mutation. Statistical analysis using a maximum likelihood approach indicated that the mutation arose 98 generations (90% confidence interval: 52–167 generations), or approximately 2,000 years, ago. Thus, 113insR would be expected to have a more widespread geographic distribution in European and North American regions with ancestral connections to Sweden. Alternatively, CDKN2A may lie in a recombination hot spot region, as suggested by the many meiotic recombinations in this narrow ∼1‐cM region on 9p21. © 2001 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers
Nobori, T., Miura, K., Wu, D. J., Lois, A., Takabayashi, K., & Carson, D. A. (1994) · Nature · doi:10.1038/368753a0 · Cited by 1,742
The p16INK4a/CDKN2A tumor suppressor and its relatives
Ruas, M., & Peters, G. (1998) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(98)00017-1 · Cited by 911
Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16
Lukas, J., Parry, D., Aagaard, L., Mann, D. J., Bartkova, J., Strauss, M., Peters, G., & Bartek, J. (1995) · Nature · doi:10.1038/375503a0 · Cited by 899 · cited 1×
“The CDKN2A product, p16-INK4A, has been identified as an inhibitor of cyclin-dependent kinases CDK4 and CDK6 (Serrano et al., 1993; Lukas et al., 1995) and induces cell-cycle G1-phase arrest by preventing the association of these kinases with D-type cyclins, thereby inhibiting phosphorylation of…”
BackgroundBorg, A., Sandberg, T., Nilsson, K., Johannsson, O., Klinker, M., Masback, A., Westerdahl, J., Olsson, H., & Ingvar, C. (2000) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/92.15.1260 · Cited by 345 · cited 3×
“…3 March 2000; Accepted 9 November 2000 Published online 30 March 2001 GENES, CHROMOSOMES & CANCER 31:107–116 (2001) © 2001 Wiley-Liss, Inc. exon 2, leading to an extra arginine at codon 113 (113insR), in 13 Swedish melanoma families (Borg et al., 1996, 2000; Platz et al., 1997).”
BackgroundMethodSelf-citationThe CDKN2A (p16) Gene and Human Cancer
Foulkes, W. D., Flanders, T. Y., Pollock, P. M., & Hayward, N. K. (1997) · Molecular Medicine · doi:10.1007/bf03401664 · Cited by 292
Estimating the Age of Mutant Disease Alleles Based on Linkage Disequilibrium
Guo, S.-W., & Xiong, M. (1997) · Human Heredity · doi:10.1159/000154431 · Cited by 30
Cited by
Goldstein, A. M., Chan, M., Harland, M., Gillanders, E. M., Hayward, N. K., Avril, M.-F., Azizi, E., Bianchi-Scarra, G., Bishop, D. T., Bressac-de Paillerets, B., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0494 · Cited by 426
Self-citationBorg, A., Sandberg, T., Nilsson, K., Johannsson, O., Klinker, M., Masback, A., Westerdahl, J., Olsson, H., & Ingvar, C. (2000) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/92.15.1260 · Cited by 345
Self-citationGenetics of melanoma predisposition
Hayward, N. K. (2003) · Oncogene · doi:10.1038/sj.onc.1206445 · Cited by 321
Melanoma etiology: where are we?
Tucker, M. A., & Goldstein, A. M. (2003) · Oncogene · doi:10.1038/sj.onc.1206444 · Cited by 268
Familial melanoma, pancreatic cancer and germline CDKN2A mutations
Goldstein, A. M. (2004) · Human Mutation · doi:10.1002/humu.9247 · Cited by 130
Metadata
- Authors
- Hashemi, J., Bendahl, P., Sandberg, T., Platz, A., Linder, S., Stierner, U., Olsson, H., Ingvar, C., Hansson, J., & Borg, Å.
- Venue
- Genes, Chromosomes and Cancer
- Publisher
- Wiley
- Published
- 2001-03-30
- Volume
- 31
- Issue
- 2
- Pages
- 107-116
- ISSN
- 1045-2257 (ISSN-L)
- 1098-2264
- OpenAlex
- W1996227395
- Cited by
- 45
- References
- 6
- FWCI
- 1.76
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Haplotype analysis and age estimation of the 113insR CDKN2A founder mutation in Swedish melanoma families. https://app.cochat.ai/papers/10.1002/gcc.1124
- The paper
- Hashemi, J., Bendahl, P., Sandberg, T., Platz, A., Linder, S., Stierner, U., Olsson, H., Ingvar, C., Hansson, J., & Borg, Å. (2001). Haplotype analysis and age estimation of the 113insR CDKN2A founder mutation in Swedish melanoma families. Genes, Chromosomes and Cancer. https://doi.org/10.1002/gcc.1124
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.